Visionary treatments using epithelial stem cells presented at TMM2015

by Guest | Dec 17, 2015

This is a guest post by Nadia Houri, a Business Development Analyst with the Centre for Commercialization of Regenerative Medicine (CCRM). In October 2015, I attended the Till & McCulloch Meetings (TMM) in Toronto, of which my employer, CCRM, was a co-organizer....

Right Turn: Stem cell books for kids

by Stacey Johnson | Dec 11, 2015

I have yet to meet a parent who doesn’t think reading to/with their kids is crucial. I’m going to assume that if you’re a scientist, instilling a love of science to your children, through books, is a priority. With winter holidays just around the corner, kids will...

Update from the Clinic: November

by Mark Curtis | Dec 10, 2015

Welcome to your Update from the Clinic for the month of November. There were a number of mid-stage clinical trials launched by cell-based immunotherapy companies this past month, furthering a robust global pipeline of CAR/TCR products. We also saw some efficacy data...

Right Turn: Making science sexy again

by Stacey Johnson | Dec 4, 2015

Justin Trudeau, Canada’s “hot” new prime minister, is getting Canadian scientists all worked up – in a good way. For the first time in nearly ten years, the scientific community has a passionate champion in Ottawa ready to undress – sorry unmuzzle – federal scientists...

Canada: Science is in our blood

by Nicole Kuchinsky | Dec 1, 2015

November was a big month for science in Canada. Our new prime minister, Justin Trudeau, sent a clear message that science will be a priority for his administration by naming Dr. Kirsty Duncan Minister of Science, and Navdeep Bains Minister of Innovation, Science and...

Right Turn: Cancer campaigns

by Stacey Johnson | Nov 27, 2015

To some people, November is now Movember. That is testament to how successful and pervasive this campaign for men’s health – especially prostate cancer – has become. (Blogger Sara Nolte has also chosen to write about prostate cancer during Movember.) Last month the...

Cell Therapy Deal Review: October

by Mark Curtis | Nov 24, 2015

Welcome to your Cell Therapy Deal Review for the month of October. Lion Biotechnologies and Kite Pharma both made deals with the National Institutes of Health (NIH) that significantly expanded their respective pipelines. Kite also announced a research collaboration...

Canadian Researchers Recognized For Diabetes Breakthrough Using Stem Cells

by Guest | Nov 23, 2015

John Farrell is a science and technology blogger for Forbes online. John was invited to cover proceedings at the 2015 Till & McCulloch Meetings and this is his first report. This blog also appears on Forbes and is reprinted here with permission.  Timothy J....

Right Turn: The art of scientific communication

by Hamideh Emrani | Nov 20, 2015

I’ve been blogging about some of the talks that I heard at the recent Till & McCulloch Meetings (TMM) in Toronto, Canada. Maybe you’ve read them (featuring speakers Molly Shoichet and Milica Radisic)? For this blog, I want to take a different focus. TMM is diverse...

Here we go…cells derived from embryonic stem cells in UK clinics

by David Kent | Nov 16, 2015

The United Kingdom has begun its foray into using cells derived from human embryonic stem cells (ESCs) in clinical settings. I have to admit I was surprised that following coverage on the BBC and in The Guardian, there was virtually no anti-ESC protesting to be found,...